Neurocrine Biosciences trial failures may 'stunt momentum,' analysts say
Company will halt development of experimental depression treatment
Source: marketwatch.com
Page 41 - Service Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Service Testing Today - Breaking & Trending Today
Ikena Oncology Shares Slump to All-Time Low After IK-930 Cancer Drug Data
By Colin Kellaher Ikena Oncology shares lost more than two-thirds of their value and hit an all-time low after the clinical-stage biotechnology company...
Source: marketwatch.com
Eli Lilly gets FDA approval for new obesity drug
Zepbound helped patients lose up to 48 pounds on average in clinical trials.
Source: marketwatch.com
Aura Biosciences Gets FDA Agreement Regarding Phase 3 Clinical Trial of Bel-Sar
By Stephen Nakrosis Aura Biosciences on Monday said it received agreement from the U.S. Food and Drug Administration for the design and plan of a Phase 3...
Source: marketwatch.com
Werewolf Therapeutics Shares Jump on Encouraging Trial Data
By Dean Seal Shares of Werewolf Therapeutics shot higher after the company presented Phase 1 trial data establishing proof of mechanism for its lead clinical...
Source: marketwatch.com